Related by context. All words. (Click for frequent words.) 74 MT# MEDI 74 humanized anti 74 Blinatumomab 74 targeted antifolate 73 vascular disrupting agents 73 HSP# inhibitor 73 investigational humanized monoclonal antibody 73 liposomal formulation 73 mda 7 73 Sphingomab 73 proteasome inhibitor 72 pan HDAC inhibitor 72 Factor Receptor 72 novel peptide 72 humanized monoclonal 72 ENMD # 72 antibody MAb 72 Fc fusion protein 72 Aurora kinase 72 selective kinase inhibitor 72 JAK1 72 CYT# potent vascular disrupting 72 PKC# 72 humanized monoclonal antibodies 72 Squalamine 72 replicon 72 Presents Preclinical Data 72 isoform selective 72 Gleevec resistant 72 orally bioavailable 72 humanized monoclonal antibody 72 Romidepsin 72 depsipeptide 71 HGS ETR2 71 JAK inhibitors 71 Guanilib 71 oral prodrug 71 JAK2 inhibitor 71 mertansine 71 anti CD3 71 poly ADP ribose polymerase 71 BiTE 71 histone deacetylase HDAC inhibitor 71 Bezielle 71 dasatinib Sprycel 71 Liposomal 71 Kinase Inhibitor 71 orally administered inhibitor 71 Janus kinase 71 non nucleoside inhibitor 71 CYC# 71 potently inhibit 71 selective inhibition 71 Epidermal Growth Factor Receptor 71 Omacetaxine 70 Onconase 70 multi kinase inhibitor 70 cetuximab Erbitux R 70 mTOR mammalian target 70 mitogen activated ERK kinase 70 orally dosed 70 PNP inhibitor 70 novel histone deacetylase 70 irreversible inhibitor 70 immunotoxin 70 immunomodulator 70 CCR9 70 MEK inhibitors 70 PEGylated Fab fragment 70 Aplidin 70 immunomodulating 70 humanized antibody 70 IAP inhibitors 70 Carfilzomib 70 drug conjugate 70 BiTE ® 70 Bafetinib 70 Tyrima 70 AAG geldanamycin analog 70 antisense drug 70 accumulate preferentially 70 Tyrosine Kinase Inhibitor 70 histone deacetylase inhibitor 70 JAK3 70 IAP inhibitor 70 Daclizumab 70 ErbB3 70 Factor VIIa 70 antitumor 70 Epratuzumab 70 MTP inhibitor 70 HuLuc# 70 Aptamer 70 Aliskiren 70 novel immunomodulatory 70 selective modulator 70 BiTE R 70 highly selective inhibitor 70 IMA# 70 Phase 2b Clinical Trial 70 NS#/#A protease 70 AKT inhibitor 70 A3 adenosine receptor 70 PDE4 inhibitor 70 protein tyrosine phosphatase 1B 70 TLR9 agonist 70 Thiovir 70 Immunotherapeutic 70 HCV protease 70 IgG1 monoclonal antibody 69 Tarvacin TM 69 HDAC Inhibitor 69 JVRS 69 Monoclonal antibody 69 Thiarabine 69 tyrosine kinase inhibitor 69 vidofludimus 69 selectively inhibited 69 NXL# 69 chimeric monoclonal antibody 69 Aurora Kinase 69 immune modulatory 69 erlotinib Tarceva ® 69 imatinib Gleevec ® 69 Hedgehog signaling pathway 69 immunomodulatory 69 rxRNA 69 5 HT2A serotonin 69 sodium glucose cotransporter 69 protein kinase inhibitor 69 Elotuzumab 69 Panzem R 69 Granulocyte Colony Stimulating Factor 69 CDK inhibitor 69 small molecule defensin 69 Bortezomib 69 geldanamycin 69 pan histone deacetylase 69 phosphate S1P 69 potent inhibition 69 Pralatrexate 69 Hsp# Inhibitor 69 peptibody 69 OXi# 69 Reports Preclinical Data 69 xenograft models 69 proprietary polysaccharide 69 MET VEGFR2 69 ALN TTR 69 IL #E 69 OMP #M# 69 Bosutinib 69 Traficet EN 69 T#I [002] 69 Multimeric 69 TRAIL induced apoptosis 69 Luteinizing Hormone Releasing Hormone 69 MAGE A3 ASCI 69 antisense inhibitors 69 potent anticancer 69 nucleoside analog 69 DNA intercalator 69 tyrosine kinase receptor 69 Anti Tumor 69 NS5b 69 peripherally acting 69 Oncolytic 69 potent cytotoxic 69 anti angiogenic agent 69 Systemic Delivery 69 targeted radiotherapeutic 69 anionic backbone 69 histone deacetylase HDAC 69 hypereosinophilic syndrome 69 YONDELIS 69 polymerase inhibitor 69 NEUGENE 69 gefitinib Iressa 69 thrombin receptor 69 murine monoclonal antibody 69 acadesine 69 Protein Kinase C 69 MT#/MEDI-# 69 Kahalalide F 69 GVAX ® 69 soluble tumor necrosis 69 peptidic compound 69 stable nucleic acid 69 entinostat 69 therapeutic monoclonal antibody 69 Angiolix 69 oncolytic 69 vinca alkaloid 69 CCR9 antagonist 69 immunoregulatory 69 Sapacitabine 68 refractory chronic lymphocytic 68 BAL# [001] 68 agonistic human 68 Monoclonal Antibody 68 Alfacell proprietary ribonuclease 68 lymphoid malignancies 68 HDACi 68 radiation sensitizer 68 Virulizin ® 68 Tarvacin 68 NS5A 68 induces apoptosis 68 proteasome inhibitors 68 Vidofludimus 68 NTDDS 68 #ME# 68 PI3K inhibitor 68 Aplidin R 68 antisense inhibitor 68 peptide antigens 68 phosphatidylserine PS targeting 68 imatinib Gleevec 68 Personalized Immunotherapy 68 Hsp# inhibition 68 dasatinib Sprycel ® 68 immune modulating 68 FLT3 68 investigational monoclonal antibody 68 receptor tyrosine kinase inhibitor 68 Cytochrome P# 68 HQK 68 Pertuzumab 68 potent inhibitor 68 IgG1 antibody 68 small molecule tyrosine 68 HuMax CD4 68 Aflibercept 68 Xanafide 68 FOLOTYN ® 68 bevacizumab Avastin ® 68 liposomal delivery 68 nucleotide analog 68 HER2/neu 68 Pathway Inhibitor 68 Maribavir 68 volociximab 68 M2 subunit 68 effector function 68 CD# monoclonal antibody 68 p# inhibitor 68 Janus Kinase 68 candidate deforolimus 68 PDE# 68 selective agonist 68 immunostimulatory 68 INGN 68 FGFR 68 IMC A# 68 somatostatin analogue 68 oral JAK1 68 Preclinical Study 68 NS5B polymerase 68 radezolid 68 ARRY # 68 HCV protease inhibitors 68 pharmacological chaperone 68 epigenetic therapies 68 E#F# 68 demethylating agent 68 anticancer therapeutics 68 mediated apoptosis 68 IMiDs R 68 EGF receptor 68 Abiraterone acetate 68 recombinant adeno associated 68 HuMax 68 Panzem R NCD 68 Upregulation 68 siRNA therapeutics 68 TRX1 68 thalidomide Thalomid 68 DermaVir Patch 68 OMP #R# 68 VitiGam 68 bispecific 68 Perifosine 68 BiTE antibody 68 Cytotoxic T 68 Azedra 68 metaglidasen 68 Chemokine Receptor 68 HCV NS3 protease 68 Antiangiogenic 68 Romiplostim 68 small molecule thrombopoietin 68 Bavituximab 68 novel VDA molecule 68 binds selectively 68 non nucleoside HCV 68 chemokine receptor 68 sunitinib Sutent ® 68 Voreloxin 68 anti amnesic 68 small molecule glucokinase 68 bortezomib Velcade 68 androgen receptor AR 68 humanised monoclonal antibody 68 Potelligent Technology 68 VEGF inhibitors 68 selective inhibitor 68 SAR# [004] 68 PXD# 68 Flt3 68 Epothilones 68 demonstrated antitumor activity 68 monoclonal antibody mAb 68 Vaccine Adjuvant 68 IL# PE#QQR 68 kinase inhibitor 68 small molecule Hedgehog 68 Anticalin R 68 BRAF inhibitor 68 MEK inhibitor 68 Androgen Receptor 68 HCV replicon 68 Pharmacokinetics PK 68 nucleotide analogs 68 anti CD# monoclonal 67 mediated inhibition 67 VEGF receptor 67 ddRNAi 67 Pegylated 67 DOS# 67 novel immunotherapeutic 67 BZL# 67 tubulin inhibitor 67 NPC 1C 67 cyclin dependent kinase inhibitor 67 Lenocta 67 oral antiviral 67 sorafenib tablets 67 DiLA2 67 Preclinical Data 67 cilengitide 67 selective orally bioavailable 67 lipoglycopeptide 67 selectively inhibits 67 potent antiproliferative 67 MAb 67 kidney urologic 67 IMiDs ® compound 67 Quinamed 67 receptor inhibitor 67 fosbretabulin 67 MUC1 67 NeoLipid R 67 RNAi therapeutic targeting 67 trastuzumab Herceptin R 67 ALK inhibitor 67 Panzem 67 Antisense 67 oncolytic virus 67 angiogenesis inhibitor 67 Annamycin 67 tumor antigen 67 R roscovitine 67 immune modulator 67 Sudhir Agrawal D.Phil 67 JAK#/JAK# 67 cancer immunotherapies 67 PPARgamma 67 PI3K/mTOR 67 sorafenib Nexavar 67 Degarelix 67 antibody MT# 67 non nucleoside 67 pediatric acute lymphoblastic 67 HGS ETR1 67 AEGR 67 ADP receptor antagonist 67 VEGFR2 67 HDAC inhibitor 67 INCB# [001] 67 hypoxia inducible factor 67 Ofatumumab 67 oral Janus kinase 67 Antitumor Activity 67 CD# CEA 67 vascular disrupting agent 67 Temsirolimus 67 selective antagonist 67 JAK2 Inhibitor 67 c MET 67 PDGF receptor 67 Apoptone 67 GRNVAC1 67 GMX# 67 telomerase reverse transcriptase 67 pro apoptotic 67 JAK inhibitor 67 PI3 kinase 67 virus AAV 67 mGlu2 3 67 GW# [003] 67 CCX# 67 OHR/AVR# 67 Ceflatonin 67 HDAC enzymes 67 acid phosphatase PAP 67 YONDELIS R 67 Panzem NCD 67 Enzastaurin 67 flavopiridol 67 KRN# 67 Zalypsis 67 essential thrombocythemia ET 67 CCR2 67 TLR9 agonists 67 antisense inhibition 67 chemically modified siRNA 67 ceftazidime 67 BCR ABL inhibitors 67 anti CD# antibody 67 Interferon gamma 67 uricase 67 virosome 67 PI3K/Akt pathway inhibitor 67 MyVax R 67 Preclinical studies suggest 67 taxane derivative 67 PEG SN# 67 Mipomersen 67 chronic eosinophilic leukemia 67 developing Bicifadine serotonin 67 EpCAM 67 CD# antibody [001] 67 Trastuzumab 67 milatuzumab 67 activin receptor type 67 antiangiogenic 67 anticancer therapies 67 cMET 67 2 methoxyestradiol 67 Avila Therapeutics 67 OncoVEX GM CSF 67 PRTX 67 ON #.Na 67 epothilones 67 ABL inhibitor 67 antisense drugs 67 histone deacetylase HDAC inhibitors 67 Pazopanib 67 p# MAPK 67 Sphingomab TM 67 myelofibrosis polycythemia vera 67 adecatumumab MT# 67 Cloretazine ® 67 selective serotonin 2C receptor 67 anti CD# antibodies 67 HER2 ErbB2 67 IMC #B 67 Recombinant Human 67 immunotherapeutic agent 67 ErbB2 positive 67 antibody fragment 67 Phase #b/#a clinical 66 autologous cellular immunotherapy 66 delta isoform 66 angiogenesis inhibition 66 HIF 1α 66 virus HCV protease inhibitor 66 investigational oral inhibitor 66 Drug Candidate 66 N acetylgalactosamine 6 66 NS4A 66 XL# inhibits 66 NKX#.# 66 beta 1a 66 adult mesenchymal stem 66 lentiviral vector 66 Marqibo TM 66 Nexavar ® 66 ELACYT 66 TRAIL R2 66 PI3K Akt 66 colon carcinoma 66 DCVax R 66 Elesclomol 66 oxidative stress inducer 66 Apaziquone 66 oral Hsp# inhibitor 66 Irinotecan 66 adenoviral 66 small molecule agonists 66 tumor vascular disrupting 66 PEGylated anti 66 G Protein Coupled 66 intratumoral injection 66 Meets Primary Endpoint 66 Talabostat 66 preclinically 66 XL# XL# 66 Trp p8 66 Symadex 66 intranasal formulation 66 TO AVOID PREGNANCY WHILE 66 antisense oligonucleotide 66 tumor specific antigen 66 histone deacetylase inhibitors 66 peptidomimetic 66 PEGylated 66 Vitaxin 66 MORAb 66 estrogen receptor beta 66 cytotoxic T lymphocyte 66 huC# DM4 66 AT1R 66 Micromet BiTE 66 Alemtuzumab 66 CCR5 antagonist 66 Ii protein 66 specific protein tyrosine 66 c KIT 66 RAF kinase 66 immune stimulatory 66 eIF 4E 66 rhIL 7 66 BRAF inhibitors 66 PKCi 66 AEG# 66 Eg5 66 POTELLIGENT ® 66 Antigen Specific 66 Vandetanib 66 selective immunoproteasome inhibitor 66 Antibody Discovery 66 interleukin IL -# 66 Polymerase Inhibitor 66 ganetespib 66 inhibit replication 66 ara C 66 Civacir 66 novel topoisomerase 66 CD# antigen 66 nilotinib Tasigna 66 mGluR2 NAM 66 CRTH2 66 novel therapeutic antibodies 66 evaluating tivozanib 66 DNA methyltransferase inhibitors 66 KSP inhibitor 66 NSCLC tumors 66 PSN# [002] 66 5 HT6 receptor 66 VEGFR2 inhibitor 66 zanolimumab 66 specific lectin receptors 66 small molecule chemotherapeutic 66 Orally administered 66 Interferon beta 66 RAS MAPK pathway 66 TLR9 66 androgen independent 66 TLR8 66 Ridaforolimus 66 K ras mutations 66 brostallicin 66 alpha antagonist 66 HER1 66 Silodosin 66 lysophosphatidic acid LPA 66 CanAg 66 Akt inhibitor 66 THR beta agonist 66 EndoTAG TM 66 Ecallantide 66 RNAi Therapeutic 66 interferon lambda 66 Seliciclib 66 Gefitinib 66 Hsp# inhibitors 66 retinoic acid receptor 66 Tezampanel 66 ADAMTS# 66 XmAb# 66 Nanobody 66 ATL# [001] 66 Anticalin ® 66 oncolytic virus therapies 66 miR #a [002] 66 Monoclonal 66 Initiate Clinical Trial 66 TG# [003] 66 OvaRex R 66 Fleximer 66 cell lymphoma CTCL 66 Everolimus 66 Presents Preclinical 66 adenoviral vectors 66 MVA BN R 66 TRAIL receptor 66 HCV RNA polymerase 66 tkRNAi 66 Therapeutic Vaccine 66 Initiates Clinical 66 polymerase inhibitors 66 alpha folate receptor 66 anti EGFR antibody 66 HuMax EGFr 66 HuMax TAC 66 tumorigenicity 66 Antibody Drug Conjugate 66 TTR gene 66 HDAC 66 antisense oligonucleotides 66 IFN α 66 immunomodulatory properties 66 pathophysiological effects 66 neuroprotective properties 66 exon skipping 66 gamma secretase inhibitor 66 microtubule targeting 66 anti CD3 antibody 66 attach auristatin 66 HuCAL GOLD R 66 bispecific antibody 66 Anidulafungin 66 KSP inhibitors 66 docetaxel Taxotere ® 66 CYP#A# CYP#D# 66 selective androgen receptor modulator 66 HTS assay 66 syngeneic 66 MVA BN 66 alvespimycin 66 Tesetaxel 66 immunoconjugate 66 BiTE Antibody 66 Campath alemtuzumab 66 Denufosol 66 miR #a [001] 66 AKT1 66 nonviral 66 Archexin 66 SERMs 66 Calcitonin 66 relapsed leukemia 66 neuronal nitric oxide synthase 66 histone deacetylase 66 MGd 66 oral dihydropyrimidine dehydrogenase DPD 66 adenosine A2A 66 signal transduction inhibitor 66 Dalbavancin 66 immatics 66 UPLYSO 66 CD# molecule 66 castrate resistant prostate cancer 66 EGFr 66 ALN PCS 66 Cathepsin S 66 HIF 1alpha 66 antitumoral 66 CEQ# 66 telomerase inhibitor 65 ASONEP 65 Cutaneous T 65 ganaxolone 65 HER3 65 Present Preclinical Data 65 generation antisense inhibitor 65 SAR# [002] 65 EGFR HER2 65 anaplastic lymphoma kinase ALK 65 Tumor Necrosis Factor 65 potent topoisomerase II 65 thymidylate synthase TS 65 systemic RNAi therapeutic 65 HCV NS5B polymerase 65 immunotherapeutic vaccine 65 IMiDs ® 65 Azacitidine 65 potently inhibits 65 maytansinoid 65 Bruton tyrosine kinase 65 ABLYNX 65 hedgehog pathway 65 TNF Tumor Necrosis Factor 65 small molecule modulators 65 Anti Tumor Activity 65 cyclin dependent kinase CDK 65 Dapagliflozin 65 pegylated 65 nucleoside 65 highly immunogenic 65 investigational immunotherapy 65 Cethromycin 65 Tumour Vascular Disrupting Agent 65 panobinostat 65 HCD# [002] 65 cisplatin resistant 65 Entry Inhibitor 65 DFMO 65 Mucosal 65 cutaneous T 65 Aviptadil 65 antiapoptotic 65 ligand TRAIL 65 imatinib resistant 65 gamma secretase inhibitors 65 Pemetrexed 65 OncoVEX 65 5 HT4 receptor 65 Sipuleucel T 65 PDX pralatrexate 65 oral proteasome inhibitor 65 Sym# 65 AVI NEUGENE 65 PI3K delta 65 Vitro Activity 65 immuno modulatory 65 human IgG1 monoclonal 65 XYOTAX TM 65 reversible inhibitor 65 Advanced Renal Cell 65 recombinant fusion 65 SMARTICLES ® 65 LPA1 65 Curaxin 65 Methylnaltrexone 65 BCR ABL 65 HER2 receptor 65 GRN# 65 Tarceva TM 65 castration resistant prostate cancer 65 glycogen synthase kinase 65 pomalidomide 65 tumor xenograft models 65 antagomirs 65 partial agonist 65 cytostatic 65 PI3K inhibitors 65 lipid nanoparticle 65 monocytes macrophages 65 neuronal nicotinic receptor NNR 65 immunotherapeutics 65 neurotrophic 65 Eribulin 65 prodrugs 65 alkylating agent 65 platform HDL Mimetic 65 anticancer agent 65 GAD# 65 demethylating agents 65 Bioral ® 65 bevacizumab Avastin R 65 dihydrofolate reductase 65 cytoprotective 65 omega interferon 65 MEK ERK 65 forodesine 65 OncoVex 65 #beta HSD1 65 TransVax tm 65 Angiolix R 65 SNT MC# 65 Cyclosert 65 Ataluren 65 HCV polymerase 65 Initiates Phase II 65 TLK# 65 LEAPS TM 65 Talactoferrin 65 siRNA therapeutic 65 small molecule activator 65 VIPR2 65 antiproliferative effects 65 Interferon Beta 65 DermaVir 65 selectively inhibit 65 Phase 2b Trial 65 PRT# 65 vaccine GRNVAC1 65 thetreatment 65 TGF beta1 65 Glufosfamide 65 acetonide FA 65 Elagolix 65 CD# expressing 65 PCK# 65 R lenalidomide 65 tubulin polymerization 65 delivered RNAi therapeutic 65 Palifosfamide 65 endothelin receptor 65 p# mitogen activated 65 activin 65 Trofex 65 investigational pan BCR 65 Curaxins 65 APOPTONE 65 selective adenosine 65 novel peptides 65 NEUGENE R 65 Cloretazine R 65 Epstein Barr Virus EBV 65 GAP #B# 65 DepoVax 65 pralatrexate injection folate analogue 65 EndoTAG TM -1 65 Initiate Phase 65 synthetic siRNA 65 compound AEZS 65 UsiRNAs 65 synthetic peptide 65 Curaxin CBLC# 65 Universal Flu Vaccine 65 anti leukemic 65 short interfering RNA 65 XL# anticancer compounds 65 pleiotropic 65 Phase Ib clinical trials 65 Anticalin 65 tests miRview TM 65 Adenoviral 65 selectively inhibiting 65 apoptosis proteins 65 delipidation 65 epithelial tumors 65 Zolinza 65 immune modulation 65 R sorafenib tablets 65 FGFR3 65 LymphoStat B TM 65 Novel Oral 65 Cyclin E 65 ESBA# 65 etanercept Enbrel 65 HGS# 65 otelixizumab 65 TREANDA 65 EndoTAG 65 Selective Inhibitor 65 personalized immunotherapy 65 tyrosine kinase inhibitor TKI 65 5 HT2C 65 EGFR inhibitors 65 triggers apoptosis programmed 65 PSMA ADC 65 anti secretory 65 peptide conjugated 65 kinase inhibition 65 Cloretazine 65 Receptor Antagonist 65 SIRT2 65 antisense 65 5 HT4 65 vapreotide acetate 65 PANVAC VF 65 fusion protein 65 vimentin 65 Campath ® 65 HCV protease inhibitor 65 Maxy G# 65 Receives Orphan Drug Designation 65 Histone Deacetylase 65 SMaRT ™ 65 Olaparib 65 polysaccharide polymer 65 potent suppressor 65 RGB # 65 hTERT 65 PLX# 65 apoptosis inducing 65 Pyridorin 65 Hedgehog Pathway Inhibitor 65 preclinical efficacy 65 metastatic malignant 65 Ocrelizumab 65 busulfan 65 MDR1 65 TRAIL Receptor 65 MGCD# [001] 65 induce apoptosis 65 inverse agonist 65 LymphoStat B belimumab 65 related apoptosis inducing 65 bleomycin 65 Epothilone D 65 receptor partial agonist 65 CD3 monoclonal antibody 65 trastuzumab DM1 T DM1 65 tubulin binding 65 Nedd4 65 leukemia AML 65 Leukine ® 65 subtype selective 65 novel emulsion formulation 65 neurokinin 1 65 pDCs 65 ribonucleotide reductase clinically validated 65 resolvins 65 CA4P 65 Hypoxia Inducible Factor 65 Receptor Antagonists 65 Trastuzumab DM1 65 topoisomerase II inhibitor 65 cyclophilin inhibitors 65 Xyfid TM 65 targets Galectin receptors 65 RAV# 65 lintuzumab 65 EphA2 65 ProMune 65 Anti VEGF 65 Interferon alfa 65 Ad5FGF 4 65 TGR5 65 Stapled Peptide 65 nucleoside reverse transcriptase inhibitor 65 Elvitegravir 65 cathepsin K inhibitor 65 radiolabeled 65 modulator SERM 65 aurora kinase 65 short hairpin RNAs 65 antifibrotic 65 iobenguane 65 pertuzumab 65 RECOTHROM R 65 HGS ETR1 mapatumumab 65 luteinizing hormone releasing 65 anti CD3 monoclonal 65 cationic lipid 65 HER2 HER3 65 hormone LHRH antagonist 65 HyperAcute 65 Epidermal Growth Factor 65 Hepatitis C Virus HCV 65 Fleximer R 65 Gleevec imatinib mesylate 65 mTOR inhibitors 65 Vidaza azacitidine 65 galiximab 65 cediranib 65 factor G CSF 65 relapsing multiple sclerosis 65 Smac mimetic 65 Inhalation Solution 65 oral ghrelin agonist 65 hydroxamic acid 65 small molecule inhibitors 65 humanized therapeutic 65 Afatinib 65 Locked Nucleic Acid LNA 65 Proxinium TM 64 MET amplification 64 HDAC inhibition 64 class anticancer quinolone 64 multitargeted 64 metastatic colorectal 64 IMPDH 64 Factor VEGF 64 developing TB4 64 5 HT6 64 small molecule inhibitor 64 HIV integrase inhibitors 64 cMet 64 Nanobody ® 64 ZFN modified 64 Pimavanserin 64 hematological cancers 64 Combination REOLYSIN R 64 Ceflatonin R 64 Imatinib mesylate 64 neratinib 64 docetaxel Taxotere R 64 nicotinic alpha 7 64 engineered RAP peptides 64 Lpathomab 64 PARP inhibition 64 thiazolides 64 EZN 64 G#DT 64 viral kinetics 64 non peptidic protease 64 systemically administered 64 adipogenic 64 Nitazoxanide 64 mTOR inhibitor 64 highly selective endothelin 64 factor HGF 64 Omacetaxine mepesuccinate 64 indibulin 64 GSK '# 64 topical gel formulation 64 PEGylated interferon 64 JAK2 inhibitors 64 decitabine 64 Xcellerated T Cells 64 Diffuse Large B 64 TLR7 agonist 64 fusion proteins